The CliniMACS Prodigy® is a closed and automated platform with the capability to manufacture various cell types on a single device, using standardized processes. It delivers consistent product quality in every batch enabling reproducible cell production. The closed system eliminates open processing steps and unnecessary operator transfers between multiple devices, significantly reducing contamination risk and associated quality variation from human intervention.
Miltenyi Biotec is a global provider of products and services that advance biomedical research and cell and gene therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. Used by scientists and clinicians around the world, our technologies cover techniques of sample preparation, cell isolation, cell sorting, flow cytometry, and cell culture. Our 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer. Today, Miltenyi Biotec has 2,500 employees in 28 countries – all dedicated to helping researchers and clinicians make a greater impact on science and health.
cell therapy,cell culture,cell processing system,Cell manufacturing,cell processing,CAR T cell manufacturing,automated cell manufacturing,automated cell processor,cell therapy manufacturing,Automated cell processing in a closed system,closed system,
0 Comments